Trevena Inc (TRVN)

[couldbebetter]

After the offering TRVN should have over $100 million in cash and
a market cap of under $500 million. The "initial" target market
in the US for Oli is $1.5 billion. Anything close to $1 billion
as "peak" sales would justify a market cap closer to $3 billion.
That would equate to a future share price of $15 billion...

Of course, that excludes the rest of the US injectable morphine
market...which totals around $8 billion (?) Plus, it excludes
all of Europe (have not read what the game plan is for that market.)
Then, our China partner could in time be significant.

I can't see how TRVN will be able to avoid a BO...sooner or later
it should be obvious that is where it will end up.